Growing pressure on healthcare payers to reduce costs, coupled with strong clinical demand for effective weight management and glycemic control solutions, is further accelerating biosimilar adoption
But given their soaring popularity, if one million people are prescribed those drugs, tens or even hundreds of thousands of people could experience the severe stomach problems, Sodhi warned
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Heartburn with semaglutide is usually dose-dependent
You're reintroducing the peptide to an environment where it can fold, move, and, unfortunately, break down